Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03326193 |
| Title | Phase 2, A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy |
| Recruitment | Active, not recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Tesaro, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Mobile | Alabama | 36604 | United States | Details | |
| GSK Investigational Site | Anchorage | Alaska | 99508 | United States | Details | |
| GSK Investigational Site | Mesa | Arizona | 85284 | United States | Details | |
| GSK Investigational Site | Burbank | California | 91505 | United States | Details | |
| GSK Investigational Site | Los Angeles | California | 90095 | United States | Details | |
| GSK Investigational Site | Fort Myers | Florida | 33908 | United States | Details | |
| GSK Investigational Site | Saint Petersburg | Florida | 33705 | United States | Details | |
| GSK Investigational Site | Westwood | Kansas | 66205 | United States | Details | |
| GSK Investigational Site | Detroit | Michigan | 48201 | United States | Details | |
| GSK Investigational Site | Detroit | Michigan | 48202 | United States | Details | |
| GSK Investigational Site | Jackson | Mississippi | 39216 | United States | Details | |
| GSK Investigational Site | Columbia | Missouri | 65212 | United States | Details | |
| GSK Investigational Site | Kansas City | Missouri | 64132 | United States | Details | |
| GSK Investigational Site | Lebanon | New Hampshire | 03756 | United States | Details | |
| GSK Investigational Site | Englewood | New Jersey | 07631 | United States | Details | |
| GSK Investigational Site | Morristown | New Jersey | 07962-1956 | United States | Details | |
| GSK Investigational Site | Albany | New York | 12208 | United States | Details | |
| GSK Investigational Site | Rochester | New York | 14642 | United States | Details | |
| GSK Investigational Site | Asheville | North Carolina | 28816 | United States | Details | |
| GSK Investigational Site | Columbus | Ohio | 43214 | United States | Details | |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15224 | United States | Details | |
| GSK Investigational Site | Providence | Rhode Island | 02905 | United States | Details | |
| GSK Investigational Site | Chattanooga | Tennessee | 37403 | United States | Details | |
| GSK Investigational Site | Kingsport | Tennessee | 37660 | United States | Details | |
| GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
| GSK Investigational Site | Fort Worth | Texas | 76104 | United States | Details | |
| GSK Investigational Site | Seattle | Washington | 98109 | United States | Details |